| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ranjith Ramasamy | Q79433916 |
| P2093 | author name string | Premal Patel | |
| Joshua Bitran | |||
| Ashaka Patel | |||
| P2860 | cites work | INSL3 as a biomarker of Leydig cell functionality | Q38099801 |
| Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids | Q41356375 | ||
| Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone | Q42479892 | ||
| Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development | Q43793797 | ||
| Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone. | Q44224626 | ||
| Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment | Q44723035 | ||
| Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy | Q44882573 | ||
| Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. | Q45101286 | ||
| Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression | Q45267325 | ||
| Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis | Q45310715 | ||
| The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men. | Q46880175 | ||
| Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. | Q50612224 | ||
| Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone | Q71441780 | ||
| Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility | Q28259258 | ||
| Congenital adrenal hyperplasia: not really a zebra. | Q33144571 | ||
| Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production | Q34024549 | ||
| Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency | Q34032007 | ||
| Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. | Q34546046 | ||
| Regulation of testicular function in men: implications for male hormonal contraceptive development | Q35207775 | ||
| Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial | Q36501771 | ||
| Follicle-stimulating hormone and human spermatogenesis | Q37004349 | ||
| Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin | Q37173461 | ||
| P433 | issue | Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | urology | Q105650 |
| reproductive medicine | Q351870 | ||
| P304 | page(s) | S58-S63 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Translational andrology and urology | Q27724139 |
| P1476 | title | Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? | |
| P478 | volume | 8 |
| Q100428126 | Association of aging and obesity with decreased 17-hydroxyprogesterone, a serum biomarker of intratesticular testosterone |
| Q97532464 | Effect of microsurgical varicocelectomy on semen parameters, serum, and intratesticular testosterone levels |
| Q89768177 | Using 17-OHP as Serum Biomarker to Monitor Therapy in Patients With Hypogonadotropic Hypogonadism |
Search more.